Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

473
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
473
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

742
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
742
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.8K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

445
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
445
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

398
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
398

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sudden Cardiac Arrest in Athletes.

The New England journal of medicine·2026
Same author

Livedoid vasculopathy in hemoglobinopathy-associated chronic leg ulcers.

Annals of hematology·2024
Same author

Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders.

The New England journal of medicine·2024
Same author

How I treat the co-occurrence of venous and arterial thromboembolism: anticoagulation, antiplatelet therapy, or both?

Blood·2024
Same author

More on Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies. Reply.

The New England journal of medicine·2023
Same author

Evaluating complement dysregulation in livedoid vasculopathy using a functional assay.

Blood advances·2023
Same journal

Multi target effects of Allium macrostemon against myocardial infarction: an integrated network pharmacology, molecular docking, and experimental study.

Journal of thrombosis and thrombolysis·2026
Same journal

Comparative effectiveness of figure-of-eight suture and manual compression for femoral venous hemostasis after atrial fibrillation ablation: A grade assessed meta-analysis.

Journal of thrombosis and thrombolysis·2026
Same journal

Tissue factor-related biomarkers during combined androgen blockade in patients with prostate cancer: A brief report.

Journal of thrombosis and thrombolysis·2026
Same journal

Opioid use disorder and clinical outcomes following percutaneous coronary intervention for acute coronary syndromes.

Journal of thrombosis and thrombolysis·2026
Same journal

Sex-based differences in clinical outcomes among cardiogenic shock patients treated with mechanical circulatory support.

Journal of thrombosis and thrombolysis·2026
Same journal

IGF-1 axis: The signalling bond in cancer-associated thrombosis and cachexia?

Journal of thrombosis and thrombolysis·2026
See all related articles

Related Experiment Video

Updated: Apr 16, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
08:54

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

341

Thrombophilia: clinical-practical aspects.

Stephan Moll1

  • 1Division of Hematology-Oncology, Department of Medicine, University of North Carolina School of Medicine, CB 7035, Chapel Hill, NC, 27599, USA, smoll@med.unc.edu.

Journal of Thrombosis and Thrombolysis
|March 1, 2015
PubMed
Summary
This summary is machine-generated.

Thrombophilia testing lacks consensus due to limited outcome data. Consider testing when results influence anticoagulation, family management, or patient understanding of thrombosis risk.

More Related Videos

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
06:59

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

133
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.6K

Related Experiment Videos

Last Updated: Apr 16, 2026

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
08:54

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

341
The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
06:59

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

133
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.6K

Area of Science:

  • Medical Science
  • Hematology
  • Clinical Genetics

Background:

  • Consensus on thrombophilia testing is lacking due to insufficient clinical outcome data.
  • Thrombophilia testing may be considered in specific scenarios, including predicting recurrent thrombosis or guiding management of asymptomatic carriers.
  • Patient desire to understand the cause of a thrombotic event is another consideration for testing.

Purpose of the Study:

  • To review the indications and optimal timing for thrombophilia testing.
  • To provide guidance on appropriate patient selection and pre-test counseling.
  • To inform healthcare professionals on the interpretation and application of thrombophilia test results.

Main Methods:

  • Literature review on clinical outcomes related to thrombophilia.
  • Analysis of decision-making processes for anticoagulation therapy.
  • Guideline development for appropriate thrombophilia testing protocols.

Main Results:

  • Testing may be beneficial for patients with intermediate risk of venous thromboembolism recurrence, aiding anticoagulation decisions.
  • Thrombophilia testing is not recommended for unprovoked venous thromboembolism triggered by major transient risk factors.
  • Testing should be performed by healthcare professionals skilled in patient selection, counseling, interpretation, and education (the "4P").

Conclusions:

  • Thrombophilia testing should be timed around the decision point for stopping or continuing anticoagulation, typically after three months.
  • Testing is not advised during an acute thrombotic event or while the patient is on anticoagulation.
  • Properly selected and counseled patients can benefit from thrombophilia testing to inform management and understanding.